Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 11/2015

01-11-2015 | Original Article

A NSQIP Review of Major Morbidity and Mortality of Synchronous Liver Resection for Colorectal Metastasis Stratified by Extent of Liver Resection and Type of Colorectal Resection

Authors: Christopher R. Shubert, Elizabeth B. Habermann, John R. Bergquist, Cornelius A. Thiels, Kristine M. Thomsen, Walter K. Kremers, Michael L. Kendrick, Robert R. Cima, David M. Nagorney

Published in: Journal of Gastrointestinal Surgery | Issue 11/2015

Login to get access

Abstract

Introduction

Safety of synchronous hepatectomy and colorectal resection (CRR) for metastatic colorectal cancer remains controversial. We hypothesized that both the extent of hepatectomy and CRR influences postoperative outcomes.

Methods

Prospective 2005–2013 ACS-NSQIP data were retrospectively reviewed for mortality and major morbidity (MM) after (1) isolated hepatectomy, (2) isolated CRR, and (3) synchronous resection for colorectal cancer. Hepatectomy and CRR risk categories were created based on mortality and MM of respective isolated resections. The synchronous cohort was then stratified based on risk categories. Cumulative asynchronous mortality and MM were estimated compared to that observed in the synchronous cohort via unadjusted relative risk and risk difference.

Results

There were 43,408 patients identified. Among isolated hepatectomy patients (N = 6,661), trisectionectomy and right hepatectomy experienced the greatest mortality and were defined as “major” hepatectomy. Among isolated CRR patients (N = 35,825), diverted left colectomy, abdominoperineal resection, total abdominal colectomy, and total abdominal proctocolectomy experienced the greatest MM and were defined as “high risk” CRR. Synchronous patients (N = 922) were stratified by hepatectomy and CRR risk categories; mortality and MM varied from 0.9 to 5.0 % and 25.5 to 55.0 %, respectively. Mortality and MM were greatest for patients undergoing “high risk” CRR and “major” hepatectomy and lowest for synchronous CRR and “minor” hepatectomy. As both CRR and hepatectomy risk categories increased, there was a significant trend in increasing mortality and MM in synchronous patients. Additionally, comparison of the synchronous resections versus the estimated cumulative asynchronous outcomes showed that (1) mortality was significantly less after synchronous minor hepatectomy and either low or high risk CRR, and (2) neither mortality nor major morbidity differed significantly after major hepatectomy with either high or low risk CRR.

Conclusion

Major morbidity after synchronous hepatic and colorectal resections vary incrementally and are related to both the risk of hepatectomy and CRR. Stratification of outcomes by the hepatectomy and CRR components may reflect a more accurate description of risks. Comparison of synchronous and combined outcomes of individual operations supports a potential benefit for synchronous resections with minor hepatectomy.
Literature
1.
go back to reference Edwards BK, Noone AM, Mariotto AB, et al. Annual Report to the Nation on the status of cancer, 1975–2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014;120:1290–1314. doi:10.1002/cncr.28509.PubMedCentralCrossRefPubMed Edwards BK, Noone AM, Mariotto AB, et al. Annual Report to the Nation on the status of cancer, 1975–2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014;120:1290–1314. doi:10.​1002/​cncr.​28509.PubMedCentralCrossRefPubMed
5.
go back to reference Goldberg RM, Sargent DJ, Morton RF, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol. 2004;22:23–30. doi:10.1200/JCO.2004.09.046.CrossRefPubMed Goldberg RM, Sargent DJ, Morton RF, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol. 2004;22:23–30. doi:10.​1200/​JCO.​2004.​09.​046.CrossRefPubMed
6.
go back to reference Saltz LB, Clarke S, Díaz-Rubio E, et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized Phase III study.; 2008. doi:10.1200/JCO.2007.14.9930. Saltz LB, Clarke S, Díaz-Rubio E, et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized Phase III study.; 2008. doi:10.​1200/​JCO.​2007.​14.​9930.
8.
16.
go back to reference Ayez N, Burger JW a, van der Pool AE, et al. Long-term results of the “liver first” approach in patients with locally advanced rectal cancer and synchronous liver metastases. Dis Colon Rectum. 2013;56:281–287. doi:10.1097/DCR.0b013e318279b743 Ayez N, Burger JW a, van der Pool AE, et al. Long-term results of the “liver first” approach in patients with locally advanced rectal cancer and synchronous liver metastases. Dis Colon Rectum. 2013;56:281–287. doi:10.​1097/​DCR.​0b013e318279b743​
22.
go back to reference Faitot F, Faron M, Adam R, et al. Two-stage hepatectomy versus 1-stage resection combined with radiofrequency for bilobar colorectal metastases: a case-matched analysis of surgical and oncological outcomes. Ann Surg. 2014;260(5):822–828. doi:10.1097/SLA.0000000000000976.CrossRefPubMed Faitot F, Faron M, Adam R, et al. Two-stage hepatectomy versus 1-stage resection combined with radiofrequency for bilobar colorectal metastases: a case-matched analysis of surgical and oncological outcomes. Ann Surg. 2014;260(5):822–828. doi:10.​1097/​SLA.​0000000000000976​.CrossRefPubMed
23.
go back to reference Abbott AM, Parsons HM, Tuttle TM, Jensen EH. Short-term outcomes after combined colon and liver resection for synchronous colon cancer liver metastases: a population study. Ann Surg Oncol. 2012. doi:10.1245/s10434-012-2515-z. Abbott AM, Parsons HM, Tuttle TM, Jensen EH. Short-term outcomes after combined colon and liver resection for synchronous colon cancer liver metastases: a population study. Ann Surg Oncol. 2012. doi:10.​1245/​s10434-012-2515-z.
26.
27.
go back to reference Roxburgh CS, Richards CH, Moug SJ, Foulis AK, McMillan DC, Horgan PG. Determinants of short- and long-term outcome in patients undergoing simultaneous resection of colorectal cancer and synchronous colorectal liver metastases. Int J Colorectal Dis. 2012;27(3):363–369. doi:10.1007/s00384-011-1339-9.CrossRefPubMed Roxburgh CS, Richards CH, Moug SJ, Foulis AK, McMillan DC, Horgan PG. Determinants of short- and long-term outcome in patients undergoing simultaneous resection of colorectal cancer and synchronous colorectal liver metastases. Int J Colorectal Dis. 2012;27(3):363–369. doi:10.​1007/​s00384-011-1339-9.CrossRefPubMed
28.
go back to reference Vigano L, Langella S, Ferrero A, Russolillo N, Sperti E, Capussotti L. Colorectal cancer with synchronous resectable liver metastases: monocentric management in a hepatobiliary referral center improves survival outcomes. Ann Surg Oncol. 2013;20(3):938–945. doi:10.1245/s10434-012-2628-4.CrossRefPubMed Vigano L, Langella S, Ferrero A, Russolillo N, Sperti E, Capussotti L. Colorectal cancer with synchronous resectable liver metastases: monocentric management in a hepatobiliary referral center improves survival outcomes. Ann Surg Oncol. 2013;20(3):938–945. doi:10.​1245/​s10434-012-2628-4.CrossRefPubMed
29.
30.
go back to reference Wise KB, Merchea A, Cima RR, Colibaseanu DT, Thomsen KM, Habermann EB. Proximal intestinal diversion is associated with increased morbidity in patients undergoing elective colectomy for diverticular disease: an ACS-NSQIP study. J Gastrointest Surg. 2014. doi:10.1007/s11605-014-2700-4.PubMedCentral Wise KB, Merchea A, Cima RR, Colibaseanu DT, Thomsen KM, Habermann EB. Proximal intestinal diversion is associated with increased morbidity in patients undergoing elective colectomy for diverticular disease: an ACS-NSQIP study. J Gastrointest Surg. 2014. doi:10.​1007/​s11605-014-2700-4.PubMedCentral
31.
go back to reference Kwaan MR, Al-Refaie WB, Parsons HM, Chow CJ, Rothenberger D a, Habermann EB. Are right-sided colectomy outcomes different from left-sided colectomy outcomes?: study of patients with colon cancer in the ACS NSQIP database. JAMA Surg. 2013;148:504–510. doi:10.1001/jamasurg.2013.1205. Kwaan MR, Al-Refaie WB, Parsons HM, Chow CJ, Rothenberger D a, Habermann EB. Are right-sided colectomy outcomes different from left-sided colectomy outcomes?: study of patients with colon cancer in the ACS NSQIP database. JAMA Surg. 2013;148:504–510. doi:10.​1001/​jamasurg.​2013.​1205.
33.
go back to reference Andreou A, Vauthey JN, Cherqui D, et al. Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy. J Gastrointest Surg. 2013;17(1):66–77; discussion p 77. doi:10.1007/s11605-012-2005-4.CrossRefPubMed Andreou A, Vauthey JN, Cherqui D, et al. Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy. J Gastrointest Surg. 2013;17(1):66–77; discussion p 77. doi:10.​1007/​s11605-012-2005-4.CrossRefPubMed
34.
go back to reference Enker WE, Merchant N, Cohen AM, et al. Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service.; 1999. Enker WE, Merchant N, Cohen AM, et al. Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service.; 1999.
40.
Metadata
Title
A NSQIP Review of Major Morbidity and Mortality of Synchronous Liver Resection for Colorectal Metastasis Stratified by Extent of Liver Resection and Type of Colorectal Resection
Authors
Christopher R. Shubert
Elizabeth B. Habermann
John R. Bergquist
Cornelius A. Thiels
Kristine M. Thomsen
Walter K. Kremers
Michael L. Kendrick
Robert R. Cima
David M. Nagorney
Publication date
01-11-2015
Publisher
Springer US
Published in
Journal of Gastrointestinal Surgery / Issue 11/2015
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-015-2895-z

Other articles of this Issue 11/2015

Journal of Gastrointestinal Surgery 11/2015 Go to the issue